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 Abstract 
 Bradykinin-related peptides, universal mediators of infl am-
mation collectively referred to as the kinins, are often pro-
duced in excessive amounts during microbial infections. We 
have recently shown that the yeast  Candida albicans , the 
major fungal pathogen to humans, can exploit two mecha-
nisms to enhance kinin levels at the sites of candidial infec-
tion, one depending on adsorption and activation of the 
endogenous kinin-generating system of the host on the fungal 
cell wall and the other relying on cleavage of kinin precur-
sors, the kininogens, by pathogen-secreted proteases. This 
work aimed at assigning this kininogenase activity to the 
major secreted aspartic protease of  C. albicans (SAP2). The 
purifi ed SAP2 was shown to cleave human kininogens, pref-
erably the low molecular mass form (LK) and optimally in an 
acidic environment (pH 3.5 – 4.0), and to produce two kinins, 
Met-Lys-bradykinin and its derivative, [Hydroxyproline 3 ]-
Met-Lys-bradykinin, both of which are capable of interact-
ing with cellular bradykinin receptors of the B2 subtype. 
Additionally, albeit with a lower yield, des-Arg 9 -Met-Lys-
bradykinin, an effective agonist of B1-subtype receptors, was 
released. The pathophysiological potential of these kinins and 
des-Arg-kinin was also proven by presenting their ability to 
stimulate human promonocytic cells U937 to release proin-
fl ammatory interleukin 1 β (IL-1 β ) and IL-6. 
 Keywords:  Candida albicans ;  candidiasis;  des-arginine 10 -
kallidin;  interleukins;  kinin receptors;  secreted aspartic 
proteases. 
 Introduction 
 Albeit common components of normal microfl ora on human 
skin and mucous membranes, unicellular fungi from the genus 
 Candida , predominantly  Candida  albicans , can cause severe 
diseases in individuals whose immune system has been weak-
ened. These include patients with AIDS or those who have 
had surgery, organ transplantation and cancer therapy who are 
all particularly prone to life-threatening deep-seated mycoses 
of almost all inner organs, fungaemia or even systemic dis-
eases, resulting in a high mortality rate (Odds et al. , 2006 ). 
 Candida albicans and other  Candida species can also cause 
a range of persistent superfi cial infections of the gastroin-
tes tinal tract, oral cavity and vagina (Mavor et al. , 2005 ). 
Owing to the gradually increasing incidence of various types 
of candidiasis over the last few decades,  Candida yeasts 
are nowadays considered as the major fungal pathogens to 
humans (Karkowska -Kuleta et al., 2009 ). 
 The major virulence factors of these fungi include the 
transition from a yeast-like form to fi lamentous forms 
(Yang , 2003 ), the binding of host cells and proteins by 
fungal surface-exposed adhesins (Chaffi n , 2008 ) and the 
secretion of a variety of hydrolytic enzymes (Schaller 
et al. , 2005 ). Within the latter, the secreted aspartic pro-
teases (SAPs) constitute one of the most effective tools 
used by the fungus to colonize and infect the host organism 
(Naglik et al. , 2003a ). SAPs play a dual role in candidial 
virulence, acting either non-specifi cally, digesting most of 
host proteins encountered to enable tissue colonization and 
to provide nutrients necessary for microbe proliferation 
(Morschh ä user et al., 1997 ), or more specifi cally, cleaving 
various regulatory proteins involved in the host defense. In 
particular, all the major systems for the biochemical homeo-
stasis of the host, which are based on proteolytic cascades 
and include complement (Gropp et al. , 2009 ), blood coag-
ulation ( R ü chel, 1983 ), fi brinolysis and kallikrein-kinin 
system (Kaminishi et al. , 1990 ; Rapala -Kozik et al., 2010 ) 
can, by default, be dysregulated by the proteolytic enzymes 
released by the microbial pathogens into the host tissues 
and body fl uids. 
 The kallikrein-kinin system generates bradykinin (BK)-
related peptides, collectively referred to as the kinins, 
which are potent vasoactive and proinfl ammatory mediators 
involved in the regulation of various physiologic and patho-
logic processes (Colman and Schmaier , 1997 ; Joseph and 
Kaplan , 2005 ). In the circulatory system, they cause vasodila-
tation, increased blood fl ow, increased vascular permeability 
and venoconstriction (Sharma , 2006 ). Involved in almost any 
kind of infl ammation, the kinins induce a secondary release 
of pro-infl ammatory mediators such as nitric oxide, prosta-
glandins and cytokines by a variety of effector cells (Blais 
et al. , 2000 ; Moreau et al. , 2005 ). The activation of the kinin-
forming system has been suggested to constitute an important 
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part of the human host defense against microbial infections 
(Oehmcke and Herwald , 2010 ). However, some kinin-exerted 
effects can be considered as  ‘ benefi cial ’ to pathogens, such 
as the enhancement of vascular permeability, which causes 
the infl ow of plasma and facilitates the availability of nutri-
ents and the spreading the pathogen within the host organism 
(Potempa and Pike , 2009 ). 
 The role of extracellular pathogen proteases has been 
well recognized in the kinin release associated with bacterial 
infections (Imamura et al. , 2005 ; Rapala -Kozik et al., 2011 ; 
and references therein) but is unsatisfactorily characterized in 
candidiasis. Kaminishi et al.  (1990) were the fi rst to suggest a 
kinin-producing potential of the major  C. albicans SAP, albeit 
indirect, based not on the simple cleavage of the proteina-
ceous kinin precursors, the kininogens, but rather on the acti-
vation of the endogenous kinin-forming cascade of the host. 
This fungal protease was shown to activate coagulation fac-
tor XII, which could then activate prekallikrein, the zymogen 
of plasma kallikrein, the dedicated kininogen-cleaving and 
BK-releasing protease. On the contrary, we recently found 
that a mixture of proteases released by  C. albicans hyphae 
effectively cleaved human kininogens and released kinin pep-
tides (Rapala -Kozik et al., 2010 ). The current work aimed to 
assign this kininogenase activity to SAP2, the major protease 
of  C. albicans released to the medium under typical yeast cul-
ture conditions. 
 Results 
 Candida albicans possesses at least ten  SAP genes, which 
are expressed at variable levels, depending on the specifi c 
culture conditions (White and Agabian , 1995 ) or on the 
infection phase in several  in vitro models of candidial infec-
tion (Naglik et al. , 2008 ). However, it is SAP2 that has been 
gene rally found to be produced in largest amounts in  C. albi-
cans cultures. In the present work, we used purifi ed SAP2 to 
degrade human kininogens, determine the cleavage patterns, 
identify kinin-like peptides within the proteolysis products 
and prove their actual pathophysiologic, proinfl ammatory 
properties. 
 Cleavage of human kininogens by purifi ed 
 C. albicans SAP2 led to the generation of kinin-like 
peptides 
 A degradation of high molecular mass (HK) and low molec-
ular mass (LK) forms of human kininogen by SAP2 was 
analyzed by sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE). Electrophoretic patterns obtained 
from a representative time-course experiment are shown in 
Figure  1 . In the SAP2-digested HK (Figure 1A), two frag-
ments with molecular masses of approximately 65 kDa 
and 55 kDa were fi rst formed, and later, on their expense, 
a 45 kDa fragment appeared, which was relatively resistant 
to further degradation. The 65 kDa and 45 kDa bands had 
the electrophoretic mobility identical to those of heavy and 
light chains of plasma kallikrein-cleaved HK, respectively 
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 Figure 1  SDS-PAGE analysis of the degradation of human kinino-
gens, HK (A) and LK (B), by SAP2. 
 Purifi ed SAP2 was incubated with HK or LK at a 1:100 
enzyme:substrate molar ratio in 50 m m citrate buffer pH 3.5 at 37 ° C 
for 0 min (lane 2), 15 min (lane 3), 30 min (lane 4), 1 h (lane 5), 2 h 
(lane 6) and 5 h (lane 7). The digests were analyzed by SDS-PAGE 
in the Laemmli system (Laemmli , 1970 ) and the protein bands were 
visualized by silver staining. Lane 8  – the sample of HK or LK incu-
bated without SAP2 under the same conditions; lane 1  – sample of 
plasma kallikrein cleaved HK. 
(Figure 1A, lane 1). By contrast, LK was completely degraded 
to small SDS-PAGE undetectable peptides (Figure 1B), while 
faint bands at 35 kDa and 20 kDa were visible over the fi rst 
2 h of SAP2 digestion. 
 In an attempt to detect kinins in the SAP2-digested kini-
nogen samples, an enzyme-linked immunosorbent assay 
(ELISA) method was fi rst used that was specifi c for the last 
fi ve amino acids of BK sequence. As shown in Figure  2 , the 
kinins were indeed formed under SAP2 action on kininogens 
in both a concentration- and time-dependent manner (Figure 
2A and 2B, respectively). However, the yield of kinin forma-
tion from HK was an order of magnitude lower than that from 
LK. 
 For LK, as the better substrate for SAP2, we also analyzed the 
pH dependence of kinin release by this protease (Figure 3). The 
kinin production was highest at pH 3.5 and gradually decreased 
with pH increase until pH 6.0, after which kinins could barely 
be detected . 
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 Met-Lys-BK and des-Arg 9 -Met-Lys-BK were identifi ed 
in the peptide mixture generated from kininogens by 
SAP2 
 In an attempt to identify the chemical nature of kinins 
produced by SAP2 from kininogens and to determine 
the mechanism of kininogen cleavage, we fi rst ana-
lyzed the SAP2-catalyzed fragmentation of a synthetic 
26-amino acid peptide (HK358-383) with the sequence 
ISLMKRPPGFSPFRSSRIGEIKEETT matching that of 
the kinin-containing domain D4 of human kininogens. 
Multiple cleavage products formed and were separated 
by high-performance liquid chromatography (HPLC) and 
identifi ed by electrospray-ionization mass spectrometry 
(ESI-MS). In Figure  4 , the time course of a representa-
tive HK358-383 fragmentation is presented in terms of 
chromatographic peak areas. Owing to highly preferable 
cleavage of peptide bonds after L360 and K379 or G376 
(numbering according to the natural kininogen sequence), 
two major products, MKRPPGFSPFRSSRIGEIK (1) and 
MKRPPGFSPFRSSRIG (2) were formed within fi rst 
15 – 30 min and quickly disappeared, giving rise to fur-
ther products. These were produced exclusively owing to 
the cleavages downstream from the kinin sequence and 
included MKRPPGFSPFRSS (4), MKRPPGFSPFRSSR (3), 
MKRPPGFSPFRS (5) and MKRPPGFSPFR (6), and were 
probably formed simultaneously but at rates decreasing in 
that order. The latter peptide is a true kinin, Met -1 -Lys 0 -BK 
(Met 0 -kallidin, MKD). The amounts of peptides 4 and 5 
slowly decreased on the time scale of hours, suggesting 
their further conversion, mainly to MKRPPGFSPF (7) and 
MKRPPGFS (8). The abundance of the two latter peptides, 
after passing a lag phase, progressively increased toward the 
end of the experiment. Peptide 7 is a potentially biologically 
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 Figure 2  Production of kinin peptides from human kininogens by 
SAP2. 
 HK (1  µ m ) and LK (1.5  µ m ) in 50 m m citrate buffer pH 3.5 were 
incubated at 37 ° C with purifi ed SAP2 at variable concentration 
for 5 h (A) or at fi xed concentration (1:50 enzyme:substrate molar 
ratio) for variable time (B). The reaction was stopped with 10  µ m 
pepstatin A. The kinin content in the samples was determined with a 
BK-dedicated ELISA kit. 
 Figure 3  Dependence of kinin release from LK by SAP2 on pH. 
 LK (1  µ m ) was incubated at 37 ° C with purifi ed SAP2 (20 n m ) in 50 
m m citrate buffer pH 3.5 – 5.5 or 50 m m phosphate buffer pH 5.5 – 6.5. 
After 5 h, the reaction was stopped with pepstatin A and the kinin 
concentration was determined by ELISA. 
30A
B
25
20
15
10
P
ea
k 
ar
ea
 (1
04
)
P
ea
k 
ar
ea
 (1
04
)
0
0
1
2
3
4
5
0 1
1
0 4
ISLMKRPPGFSPFRSSRIGEIKEETT (0)
MKRPPGFSPFRSSRIGEIK (1)
MKRPPGFSPFRSSRIG (2)
MKRPPGFSPFRSSR (3)
MKRPPGFSPFRSS (4)
MKRPPGFSPFRS (5)
MKRPPGFSPFR (6)
MKRPPGFSPF (7)
MKRPPGFSP (8)
3
2
2 3
Time (h)
4 5
0 1
5
6
8 7
2 3
Time (h)
4 5
5
 Figure 4  HPLC/MS analysis of the hydrolysis of synthetic peptide 
HK358-383 by SAP2. 
 SAP2 was incubated with 10  µ m HK358-383 peptide in 50 m m cit-
rate buffer pH 3.5 at 37 ° C at a 1:50 enzyme:substrate molar ratio. At 
specifi ed time, the reaction was stopped with pepstatin A. The pep-
tides formed were separated by reversed-phase HPLC and identifi ed 
by ESI-MS. The time-course in terms of peak areas are shown for 
the major products formed in the early phase (A) and less abundant 
products which increased toward the end of the experiment (B). 
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 Figure 5  HPLC/ELISA analysis of kinins released from human 
kininogens by SAP2. 
 1  µ m HK (A) and 1.5  µ m LK (B) were incubated in 50 m m citrate buf-
fer pH 3.5 with purifi ed SAP2 at 37 ° C for 5 h. The obtained peptide 
mixture were separated by HPLC and the eluted fractions (0.5 ml) 
were collected, evaporated and analyzed for kinin content by ELISA 
(bars). Chromatograms of the kininogens, incubated for 5 h in the 
buffer without SAP2 (dashed line) and of the kinin mixture (dotted 
line) containing KD, BK and MKD are superimposed on the chro-
matograms of the digested kininogens (solid line). 
 Table 1  ESI-MS identifi cation of the peptides generated from LK by SAP2. 
Elution time (min) m/z Molecular mass from 
mass spectra (Da)
Peptide amino acid sequence
34 – 34.5 504.0 ( + 3), 755.4 ( + 2) 1508.8 MKRPP(OH)GFSPFRSS
34.5 – 35, 35 – 35.5 413.2 ( + 4), 550.6 ( + 3), 825 ( + 2) 1648.8 MKRPPGFSPFRSSR
36 – 36.5 498.6 ( + 3), 747.9 ( + 2) 1492.8 MKRPPGFSPFRSS
 445.9 ( + 3), 668.4 ( + 2)  1334.7  MKRPP(OH)GFSPFR 
36.5 – 37 498.6 ( + 3), 747.4 ( + 2) 1492.8 MKRPPGFSPFRSS
37 – 37.5 469.6 ( + 3), 703.9 ( + 2) 1405.9 MKRPPGFSPFRS
 38 – 38.5, 38.5 – 39  440.6 ( + 3), 660.4 ( + 2)  1318.7  MKRPPGFSPFR 
40.5 – 41 456.0 ( + 4), 607.4 ( + 3) 1819.1 MKRPPGFSPFRSSRIG
 44 – 44.5  582.3 ( + 2)  1162.6  MKRPPGFSPF 
The identifi ed kinins and des-Arg-kinin are marked with bold font. 
active kinin metabolite, des-Arg 9 -Met -1 -Lys 0 -BK (des-Arg 10 -
Met 0 -kallidin, des-Arg-MKD). It was unlikely to have been 
formed from MKD (peptide 6), as in separate experiments 
we showed that this kinin was completely resistant to SAP2 
(endopeptidase) action (data not shown). It should also be 
emphasized that, apart from peptides 7 and 8, all earlier 
products of SAP2-catalyzed fragmentation of HK358-383 
contained the intact kinin sequence. 
 The above predictions from the SAP2-mediated cleavage 
of the synthetic peptide, mimicking the domain D4, were 
verifi ed using native kininogens as SAP2 substrates. The 
chromatograms of samples obtained after extensive diges-
tion of HK and LK by SAP2 are shown in Figure  5 . While 
no peptides with the same retention times as the standards of 
the major kinins, i.e., BK and kallidin (Lys-BK, KD), could 
be detected, minor peaks with the retention time correspond-
ing to that of MKD were visible, especially in the LK digest 
(Figure 5B). The peptide fractions were collected and ana-
lyzed for kinin content by ELISA. Two ELISA-positive frac-
tions were found (Figure 5), one major at the same retention 
time as that of MKD and another, smaller, slightly shifted to a 
shorter retention time relatively to BK standard. 
 The peptide fractions from the HPLC separation of LK, 
digested with SAP2, were also analyzed by ESI-MS to iden-
tify the major products formed and eluted within the  ‘ kinin 
retention time window ’ (32 – 46 min). A list of identifi ed pep-
tides are presented in Table  1 , and the mass spectra of two 
fractions that gave positive reading on ELISA tests for kinins 
(see above) are shown in Figure  6 . 
 The major fraction of ELISA-detectable kinin, eluted at 
38 min, was proven to be relatively pure MKD. The second 
kinin-positive fraction with the shorter elution time of 36 min 
contained two peptides with estimated molecular masses of 
1492.8 Da and 1334.7 Da. The latter differed in mass from 
MKD by 16 Da and was fi nally identifi ed by MS-MS, i.e., 
with the analysis of parental ion fragmentation in the mass 
spectrometer, to have hydroxyproline (Hyp) in the fi fth posi-
tion of its sequence, otherwise identical to that of MKD. This 
compound gave a BK-equivalent response in the ELISA test 
used in this work. Albeit barely visible on chromatograms and 
undetectable on ELISA, des-Arg-MKD (eluted at  ∼ 44 min) 
was also identifi ed as a very minor product of LK fragmenta-
tion by SAP2 (Table 1). 
 Met-Lys-BK and des-Arg 9 -Met-Lys-BK, generated from 
kininogens by SAP2, interacted with cellular kinin 
receptors 
 Independently from the chemical identifi cation of the kinin-
like products of kininogen fragmentation by SAP2, the mix-
tures of SAP2-generated kininogen fragments were tested for 
interaction with the two known subtypes of kinin receptors, 
RB1 and RB2, specifi c for des-Arg-kinins and normal-length 
kinins, respectively. For that purpose, a radioreceptor assay 
was used, based on a competition of kinin-like peptides with 
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tritium-labeled BK for binding to HEK 293 cells that stably 
overexpress RB2 or with tritium-labeled des-Arg 10 -kallidin 
(DAKD) for binding to HEK 293 with overexpressed RB1. 
The SAP2-generated digests of LK were found to interact 
with both of these two subtypes of kinin receptors (Figure  7 ), 
though much more strongly with RB2. 
 These receptor-binding activities in the crude SAP2-digest 
of LK were further assigned to the fractions collected upon 
its separation by HPLC, such as that presented in Figure 5B. 
The RB2-binding peptides were found in the fractions eluted 
at 35.5 – 36 and 37.5 – 38.5 min (Figure  8 A), the same that 
showed the presence of ordinary kinins on ELISA tests and, as 
evidenced by mass spectrometric analysis, contained [Hyp 4 ]-
MKD and MKD, respectively. The RB1-binding activity was 
solely assigned to the fraction eluted at 44 – 45.5 min (Figure 
8B), in which des-Arg-MKD was identifi ed. 
 Finally, using the samples of pure, chemically synthesized 
MKD and des-Arg-MKD, we compared their affi nities to 
kinin receptors with those of more typical kinins and des-
Arg-kinins. The sets of corresponding displacement plots 
are shown in Figure  9 . While des-Arg-MKD was found to be 
equivalent to DAKD, generally considered as the best agonist 
of human RB1, MKD had a lower, by an order of magnitude, 
affi nity to RB2 as compared with that of BK or KD. 
 Figure 7  Cellular kinin receptor-binding assay of peptides pro-
duced from LK by SAP2. 
 Monolayers of HEK 293 cells with over-expressed RB2 (solid bars) 
or RB1 (dashed bars) were incubated at 4 ° C with mixtures of a diluted 
sample of SAP2-digested LK (at 1:50 molar ratio) and 2 n m [ 3 H]-BK 
or 1 n m [ 3 H]-DAKD, respectively. As a control, native undigested LK 
incubated for 5 h in 50 m m citrate buffer pH 3.5 at 37 ° C, was used. 
After washing, the cell surface-bound [ 3 H]-BK or [ 3 H]-DAKD were 
dissociated by acetic acid/NaCl treatment and the released radioactiv-
ity was measured in a beta-counter. The amounts of kinin-like pep-
tides in the samples were estimated from calibration plots, prepared 
with MKD or des-Arg 10 -MKD, respectively (see Figure 9). 
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 Figure 8  Cellular kinin receptor-binding assay of HPLC-separated 
peptides produced from LK by SAP2. 
 Collected and evaporated half-minute fractions after HPLC separa-
tion (see Figure 5B) of the LK sample, treated with SAP2 at 50:1 
molar ratio were analyzed by competitive radioreceptor-assay with 
RB2-expressing (A) or RB1-expressing (B) HEK 293 cells and 
[ 3 H]-BK or [ 3 H]-DAKD as radioactive tracers, respectively (as 
described under the Figure 7). 
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 Figure 6  ESI-MS spectra of kinins generated from LK by 
SAP2. 
 Fractions after HPLC separation of LK digests (Figure 5B), with elu-
tion time of 36 – 36.5 min (A) and 38 – 38.5 (B) were evaporated to 
dryness, dissolved in 30 % methanol with 0.1 % HCOOH and ana-
lyzed with an ESI-ion trap mass spectrometer. 
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 Met-Lys-BK stimulated human promonocytic U937 
cells to secrete proinfl ammatory interleukins 
 A typical biological effect of kinins, the stimulation of vari-
ous cells to release other proinfl ammatory mediators, was 
also determined for the kinin MKD generated by SAP2 from 
kininogens. The U937 cell line was used as a cellular model 
and the secretion of two proinfl ammatory interleukins (ILs), 
IL-1 β and IL-6, under the infl uence of lipopolysaccharide 
(LPS), kinin standards or the samples of SAP2-digested 
LK was analyzed with specifi c ELISA kits (Figure  10 ). It 
was found that 1 n m MKD, similarly to BK, could trigger 
these infl ammatory pathways (Figure 10A) and that, with 
the increasing concentration of MKD in the cell suspension, 
the concentration of the cell-secreted IL-1 β and IL-6 also 
increased (Figure 10B). 
 Discussion 
 The basic mechanisms underlying the activation of the kal-
likrein-kinin system during bacterial infections (Imamura 
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 Figure 9  Plots of the displacement of [ 3 H]-BK from RB2-
expressing HEK 293 cells (A) or [ 3 H]-DAKD from RB1-expressing 
HEK 293 cells (B) by full length kinins and des-Arg-kinins. 
 Calibration plots for the cellular kinin receptor-binding assay per-
formed as described under Figure 7 but with solutions (15 pm to 50 
 µ m ) of pure kinins: BK ( ▲ ), KD ( ▼ ) and MKD bradykinin ( ) as 
well as pure des-Arg-kinins: des-Arg 9 -BK ({ ), des-Arg 10 -KD ( z ) and 
des-Arg 10 -MKD ( ). 
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 Figure 10  Secretion of IL-1 β and IL-6 by human promonocytic 
U937 cells under the infl uence of MKD, released from LK by 
SAP2. 
 Undifferentiated U937 cells (4 × 10 6 cells) were incubated for 24 h 
in 250  µ l RPMI 1640 medium with 2 % FBS supplemented with 
100 ng/ml LPS (positive control), 1 n m kinin standards of BK, KD, 
MKD (A), SAP-2-degraded LK predicted to contain 1 n m MKD 
(A) or diluted samples of the last one, predicted to contain 0.1-5 n m 
MKD (B). Samples of SAP2 served as negative control, and the 
readings from those control samples were subtracted from the results 
obtained for other test samples. The concentration of IL-1 β (solid 
bars) and IL-6 (dashed bars) in the supernatants from above the cells 
were determined by specifi c ELISA tests. 
et al. , 2004 ) have recently been suggested to contribute 
also to the virulence of  Candida yeasts, the major fungal 
pathogens to humans. The fi rst one involves the assembly 
of components of the endogenous kinin-forming system of 
the host on the pathogen surfaces, including the primarily 
adsorbed kininogens (kinin precursors) and kallikreins as the 
fi nal kinin-releasing proteases (Rapala -Kozik et al., 2008 ; 
Karkowska -Kuleta et al., 2010 , 2011 ). The other pathway 
engages extracellular proteases of the pathogen to activate 
the upstream-acting zymogens of the host kinin-generating 
cascade (Kaminishi et al. , 1990 ) or to cleave the kininogens 
directly (Rapala -Kozik et al., 2010 ). The latter mechanism 
was reported for the mixture of proteases released by fi lamen-
tous forms of  C. albicans and several other  Candida species. 
However, it was not determined which of the ten different 
SAPs produced by  C. albicans could be assigned this kinino-
genase activity. 
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 In this work, we showed that it was SAP2 that reproduced 
most of the kinin-releasing characteristics previously deter-
mined for the unfractionated SAP mixture. We also identi-
fi ed the kinins formed and confi rmed their actual biological 
(proinfl ammatory) activity. 
 Our study revealed striking differences between the two 
forms of human kininogen in their susceptibility to SAP2-
catalyzed processing (Figures 1 and 2). LK was quickly 
degraded to a mixture of small peptides, containing kinins 
in a reasonable yield of approximately 10 % of kininogen 
molecules  ‘ productively ’ processed toward the kinin release. 
On the contrary, HK was fi rst split into big fragments, with 
molecular masses corresponding to those of heavy and light 
chains normally generated from HK by kallikreins. The 
heavy chain, which is the same as in LK, was then degraded, 
but the HK light chain seemed to persist for a relatively long 
time. This observation can be relevant to numerous recent 
reports of unique functions of this part of the HK molecule 
(Lalmanach et al. , 2010 ), particularly of its cell surface-binding 
domain D5, sometimes referred to as the  ‘ kininostatin ’ 
(Colman et al. , 2000 ). These functions, apparently masked 
in the full-length kinin-containing HK, include, but are not 
limited to, specifi c proinfl ammatory cellular signaling (Khan 
et al. , 2006 ), different from that triggered by the interac-
tion of kinins with their cellular receptors (Leeb -Lundberg 
et al., 2005 ). Consistent with that hypothesis, the yield of 
kinin production from HK was an order of magnitude lower 
than that from LK, additionally suggesting some shielding 
of the kinin-containing domain D4 by the light chain against 
SAP2 action. According to a generally accepted model, 
the two forms of human kininogens play different roles at 
local infl ammatory foci, LK being the preferable substrate 
for kinin production in the fl uid phase by tissue kallikrein 
(Joseph and Kaplan , 2005 ) and HK being a substrate for the 
cell surface-localized kinin release, primarily by plasma kal-
likrein (Reddigari et al. , 1995 ; Barbasz et al. , 2008 ; Barbasz 
and Kozik , 2009 ). In the context of candidiasis, our pres-
ent fi ndings suggest that the two mechanisms of the fungal 
infection-associated upregulation of kinin-forming systems, 
i.e., the pathogen cell wall-dependent contact system activa-
tion vs. the release of kinins from kininogens by SAPs, have 
distinct signifi cances. 
 The SAP2-catalyzed cleavage of the synthetic peptide, 
mimicking the kininogen domain D4 (HK358-383) pro-
duced several major peptides that contained the internal kinin 
sequence intact (Figure 4) and, hence, could still potentially 
be the sources of kinins  in vivo under actions of other pro-
teases, from either the pathogen or the host. However, slower 
minor cleavages in the presence of SAP2 led to the forma-
tion of a small amount of a true kinin, MKD, together with 
traces of des-Arg 10 -MKD and des-Arg 10 -des-Phe 9 -MKD. 
MKD was also identifi ed in the SAP2-generated digests of 
kininogens (Figures 5 and 6). Additionally, [Hyp 4 ]-MKD was 
found, obviously owing to the post-translational modifi ca-
tion of kininogens, which happens with approximately 30 % 
frequency in the human population and results in an occur-
rence of hydroxyproline in the third position of BK sequence 
(Sasaguri et al. , 1988 ). 
 The kininogen digests, obtained by SAP2 action, were 
also shown to possess biological activities characteristic of 
kinins and des-Arg-kinins. The mixture of SAP2-generated 
fragments of LK was found to interact with HEK 293 cells 
engineered to overexpress kinin receptors on their cell mem-
brane (Figure 7). The tests for RB2-binding, performed on 
peptide fractions obtained from the HPLC separation of 
SAP2-digested LK, unequivocally assigned this activity to 
fractions shown to contain MKD and [Hyp 4 ]-MKD (Figure 
8). Conversely, RB1-binding was solely found in the fraction, 
in which des-Arg-MKD was detected. 
 MKD is a rather rare kinin, confi rmed, for example, to 
occur in human urine (Hial et al. , 1976 ) and to be formed 
from kininogens by human renal acid proteinase (Gomes 
et al. , 1997 ), from LK by a mixture of elastase and plasma 
kallikrein (Sato and Nagasawa , 1988 ) or from HK by a 
combination of the neutrophil proteinase-3 and angiotensin 
converting enzyme (Gera et al. , 2011 ). Albeit assumed to 
have proinfl ammatory properties comparable to those of BK 
and KD, this peptide has not been satisfactorily characterized 
as an agonist of kinin receptors. In this work, using pure, 
synthetic MKD, we found that its affi nity to RB2 receptors 
was an order of magnitude lower than those of the two major 
kinins, BK and KD (Figure 9A). This fi nding does not neces-
sarily mean that the overall biological activity of this kinin 
 in vivo is insuffi cient, as numerous aminopeptidases known 
to be abundantly present in body fl uids and at the infl amma-
tion sites (Moreau et al. , 2005 ) can remove the N-terminal 
methionyl residue from this peptide and thus upgrade it to 
highly effi cient RB2 agonists. On the contrary, des-Arg-
MKD was found to be equivalent to DAKD (Figure 9B), 
the best agonist of human RB1, the receptor known to be 
involved in chronic infl ammation. 
 In this work, we also preliminarily tested the kinin and des-
Arg-kinin, released from kininogens by SAP2, for another 
biological activity typical of this group of bioactive peptides, 
namely the ability to induce the release of secondary proin-
fl ammatory mediators by a variety of cells involved in the 
propagation of infl ammatory state (Sainz et al. , 2007 ). We 
showed that the SAP2-generated digest of LK stimulated the 
human U937 promonocyte cells to secrete two proinfl amma-
tory ILs, IL-1 β and IL-6 (Figure 10) and that the pure syn-
thetic MKD had an IL-releasing activity equivalent to those 
of BK and KD. The same equivalence was observed between 
corresponding des-Arg-kinins. Preliminary tests showed that 
the IL production was signifi cantly quenched in the presence 
of kinin receptor antagonists such as HOE140 (results not 
presented). 
 The current study of the action of purifi ed SAP2 on human 
kininogens reproduced all characteristics previously deter-
mined for the kininogen cleavage by the mixture of proteases 
released by  C. albicans hyphae (Rapala -Kozik et al., 2010 ), 
except the increase of kinin production toward neutral pH. 
This suggests that at a higher pH, when the activity of SAP2 
is reduced, other proteinases take over its role. These may 
include other  C. albicans SAPs with more neutral pH optima, 
such as the SAP4-6 subset (Naglik et al. , 2003a ), or serine- 
or metalloproteinases that occasionally have been reported to 
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occur in this yeast species (Rodier et al. , 1999 ; dos Santos 
et al. , 2006 ). 
 Nevertheless, the current study strongly suggests that 
SAP2 can play the kinin-releasing role in some infections in 
niches of low pH such as stomach, vagina or urinary tract 
and/or where this protease dominates over the other SAPs. 
Unfortunately, reports on the relative expression levels of 
the ten SAPs of  C. albicans present contradictory pictures, 
depending on the infection model applied (Naglik et al. , 1999, 
2003b ; Taylor et al. , 2005 ). However, in general, the expres-
sion of SAP2 was usually high and stayed relatively constant 
during the infection progress (Naglik et al. , 2008 ). 
 Conclusions 
 In this work, purifi ed SAP2, the major secreted protease of 
 C. albicans , was shown to cleave human kininogens, with a 
high preference to LK as substrate. The mixture of SAP2-
generated kininogen fragments contained MKD and its deriv-
ative with a hydroxyproline residue at the forth position, both 
being potent agonists of cellular BK receptors of subtype B2, 
involved in immediate infl ammatory reactions. Small amounts 
of des-Arg 10 -MKD were also detected and found to be excel-
lent agonists of BK B1-subtype receptors, which are induced 
and involved in chronic infl ammations. The SAP2-cleaved 
kininogen was also shown to stimulate human promonocyte 
U937 cells to release proinfl ammatory ILs IL-1 β and Il-6. 
Because SAP2 is abundantly secreted by yeast in the culture 
and some infection models, our results suggest a major role 
for it in kinin release during candidiasis. 
 Materials and methods 
 Yeast strain and yeast culture media 
 The  C. albicans ATCC 10231 strain from the American Type Culture 
Collection (Manassas, VA, USA) was grown on YPD medium (2 % glu-
cose, 1 % peptone, 0.5 % yeast extract), obtained from Sigma (St. Louis, 
MO, USA), at 30 ° C overnight in a rotary shaker. Citrate buffered (15 
m m , pH 4.0) YCB (1.2 % ) medium (Sigma), supplemented with 0.2 % 
bovine serum albumin (BSA, Sigma) was used for SAP2 induction. 
 SAP2 production and purifi cation 
 SAP2 was obtained from the  C. albicans culture supernatant. About 
2 × 10 8 yeast cells grown in YPD medium to late logarithmic phase 
were inoculated to 1 l of 1.2 % YCB medium containing 0.2 % BSA 
and grown for 72 h at 30 ° C. The culture was centrifuged (3000  g , 
15 min, 4 ° C) and the supernatant was concentrated approximately 
100-fold in an Amicon ultrafi ltration chamber with Ultracel YM 
membrane (10 kDa molecular mass cut-off, Millipore, Billerica, 
MA, USA). The SAP2 purifi cation was performed by ion exchange 
chromatographic methods adapted from Smolenski et al.  (1997) . 
The concentrated supernatant was dialyzed against 20 m m Tris-HCl 
buffer pH 6.5 and applied to a pre-equilibrated Resource TM Q (GE 
Healthcare/Pharmacia, Uppsala, Sweden) 1 ml column and eluted 
with 30 ml linear gradient from 20 m m Tris-HCl pH 6.5 to the same 
buffer with 0.5 m sodium chloride (NaCl), at a fl ow rate of 1 ml/min 
and with spectrophotometric detection at 280 nm. Fractions with 
detectable proteolytic activity (see below) were pooled and dialyzed 
against 20 m m Tris-HCl buffer pH 6.5. The SAP2-containing sample 
was then applied to a pre-equilibrated Pharmacia Mono Q HR 5/5 
column and eluted with 20 ml linear gradient to 0.3 m NaCl in the 
same Tris buffer at a fl ow rate of 1 ml/min and with spectrophotomet-
ric detection at 280 nm. The pooled active fractions were analyzed 
for protein content by the BCA method (Smith et al. , 1985 ), using 
BSA as a standard. The purifi ed protein passed homogeneity tests by 
SDS-PAGE in the Laemmli system (Laemmli , 1970 ), using reducing 
sample buffer, 12 % gel and band visualization by silver staining. The 
purifi ed SAP2 was stored frozen at -20 ° C. 
 During the preparation, the proteolytic activity was determined 
against azocasein as a substrate (modifi ed after Morrow et al. , 1992 ). 
A 30  µ l volume of concentrated supernatant/fraction was incubated 
with 100  µ l of 1 % azocasein (Sigma) in 50 m m citrate buffer pH 
3.5 at 37 ° C for 3 h. After incubation, the undigested substrate was 
precipitated with 15 % trichloroacetic acid (TCA) and removed by 
centrifugation (10 000  g , 5 min). The supernatant was then neutral-
ized with 1 m NaOH and the concentration of the soluble products 
of the proteolytic reaction was determined by absorbance measure-
ments at 440 nm in a Power WaveX-Select microplate reader (Bio-
Tek Instruments, Winoosky, VT, USA). 
 The identity of SAP2 was confi rmed by trypsin digestion followed 
by LC/MS/MS analysis and database search. The purifi ed protein 
(10  µ g) was suspended in 50 m m NH 4 HCO 3 with 0.1 % SDS and 1 m m 
CaCl 2 , and reduced with 5 m m dithiothreitol (DTT, Bioshop Canada 
Inc., Burlingron, ON, Canada) for 60 min at 60 ° C. After cooling to 
room temperature, the reduced protein was alkylated with 10 m m io-
doacetamide (Sigma) for 20 min in the dark. The Sequencing Grade 
Modifi ed Trypsin (Promega, Madison, WI, USA) was added at a 1:50 
trypsin:target protein ratio and incubated for 3 h at 37 ° C. After that time, 
the ratio of enzyme:substrate was increased to 1:25. The sample (32  µ l) 
was incubated overnight at 30 ° C and then the reaction was stopped by 
addition of 3  µ l of 1 m HCl. The resulting peptide mixture (100  µ l of 
fourfold diluted sample) was separated by HPLC on a Eurosil Bioselect 
300-5 C-18 column (Knauer, Berlin, Germany) at a fl ow rate of 1 ml/
min with a spectrophotometric detection at 215 nm. Chromatography 
was performed in a two solvent system [solvent A: 0.1 % trifl uoroacetic 
acid (TFA, spectrometric grade, Sigma) in HPLC grade water; sol-
vent B: 0.08 % TFA in 80 % acetonitrile (HPLC gradient grade, Merck, 
Darmstadt, Germany)], with a linear gradient from 1 to 55 % of B in 90 
min. Collected peptides were evaporated, resuspended in 30 % metha-
nol (Merck) with 0.1 % HCOOH (Sigma) and analyzed by HCT Ultra 
ion-trap mass spectrometer (Bruker, Bremen, Germany), equipped with 
an ESI ion source. Raw MS/MS data were processed automatically and 
Mascot compatible fi les (*.mgf) were created using DataAnalysis TM 
4.0 software (Bruker). Tandem MS data were submitted to an in-house 
server with a version 2.3.0 Mascot software (Matrix Science, London, 
UK) (Perkins et al. , 1999 ), for a search against the Swiss-Prot database 
with taxonomy restricted to fungi. The following search parameters 
were applied: instrument type  – ESI-TRAP; enzyme specifi city  – 
trypsin; 1 + , 2 + and 3 + ions; peptide mass tollerance  –  ± 0.5 Da; MS/MS 
fragment ion mass tolerance  –  ± 0.3 Da; permitted number of missed 
cleavage  – 1;  13 C = 1. From this analysis, the purifi ed protein was un-
equivocally identifi ed as  C. albicans SAP2, with 53.5 % sequence cov-
erage and Mascot score equal to 432. 
 Electrophoretic analysis of kininogen degradation 
by SAP2 
 HK (Enzyme Research Laboratories, South Bend, IN, USA) and 
LK (Sigma) (1 and 1.5  µ m , respectively) were incubated with SAP2 
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(100:1 molar ratio) at 37 ° C for variable time (from 15 min to 5 h) in 
50 m m citrate buffer pH 3.5 and the reaction was stopped by 10  µ m 
pepstatin A. Digests from 1  µ g kininogen were separated by SDS-
PAGE in the Laemmli system, using reducing sample buffer and a 
12 % gel, and detected by silver staining. 
 HPLC analysis of the SAP2-catalyzed fragmentation 
of HK, LK and HK358-383 peptide 
 HK (1  µ m ), LK (1.5  µ m ) and the synthetic HK358-383 peptide with 
the sequence ISLMKRPPGFSPFRSSRIGEIKEETT matching that 
of the kinin-containing domain D4 of human kininogens (10  µ m , 
LipoPharm.pl, Zblewo, Poland) were cleaved by SAP2 (at 25:1, 50:1 
or 100:1 molar ratio) in 50 m m citrate buffer pH 3.5 at 37 ° C for 5 h 
(kininogens) or for variable time from 15 min to 5 h (HK358-383) 
and the reaction mixtures (100  µ l) were mixed with 20  µ l 1 m HCl to 
stop the reactions. The peptide mixtures obtained were separated on 
a Eurosil Bioselect 300-5 C-18 reversed-phase HPLC column (5  µ m, 
4 × 250 mm) equipped with a precolumn (Knauer), at a fl ow rate of 
1 ml/min with a spectrophotometric detection at 215 nm. The separa-
tion was performed in a two solvent system (solvent A: 0.1 % TFA, 
solvent B: 0.08 % TFA in 80 % acetonitrile) with a linear gradient 
from 10 % to 30 % B in 50 min. Fractions containing distinct products 
of HK358 – 383 degradation or half-minute fractions from the separa-
tion of degraded kininogens were collected, evaporated to dryness 
and after dilution analyzed by MS and ELISA for the presence of 
kinins (see below). 
 MS analysis of SAP2-catalyzed degradation 
of HK358-383 and kininogens 
 The vacuum-dried peptide fractions were dissolved in a mixture of 
30 % methanol (Merck) and 0.1 % formic acid (Sigma) and analyzed 
in a HCT Ultra mass spectrometer (Bruker), with ESI source and ion 
trap analyzer. Samples were injected into ESI source at a fl ow rate of 
3  µ l/min using a syringe pump (KD Scientifi c, Holliston, MA, USA). 
The analyses were performed in a positive ion mode in m/z range 
between 100 and 1700 with a capillary voltage of 3.5 kV, nebulizer 
pressure 10 psi and with drying gas fl ow of 5 l/min and temperature 
300 ° C. The mass spectra acquired were analyzed using a Bruker ’ s 
Data Analysis software version 4.0. 
 Determination of kinins by ELISA 
 BK-like peptides were determined with an ELISA kit (Pennisula 
Laboratories-Bachem, San Carlos, CA, USA), strictly follow-
ing the manufacturer ’ s instructions. In this assay, specifi c for the 
fi ve C-terminal amino acid residues of BK, biotinylated BK com-
petes with kinins in the analyzed samples for the binding to the 
microplate-immobilized antiserum. The amount of the biotinylated 
tracer bound was determined using streptavidin-conjugated horse-
radish peroxidase/3,3 ′ ,5,5 ′ -tetramethylbenzidine (SA-HRP/TMB) 
system and the kinin concentration in the sample was estimated from 
a calibration curve prepared with BK in a concentration range of 
0.1-5 n m . 
 Competitive kinin radioreceptor-assay 
 Generation and culturing of HEK 293 cells with stable overexpres-
sion of B1 and B2 receptors: the method of obtaining HEK 293 cell 
lines with overexpressed kinin receptors (RB1 or RB2) using the Flp-
In T-Rex-system from Invitrogen (Carlsbad, CA, USA) was described 
previously (Zubakova et al. , 2008 ). The HEK 293 cells were cultured 
in DMEM medium (PAA, Pasching, Austria) with high glucose,  l -
glutamine and sodium pyruvate supplemented with 10 % fetal bovine 
serum (FBS, Lonza, Switzerland) and penicillin/streptomycin (0.1 
mg/ml, PAA). For the binding experiments, the cells were seeded 
in 96-well plates pre-treated with 0.01 % solutions of poly- l -lysine 
(Sigma) in phosphate-buffered saline (PBS, PAA), to full confl uence. 
 Competitive radioreceptor assay ( N ä gler et al., 2010 ): after wash-
ing the cell-monolayer twice with cold PBS, HEK 293 cells were 
equilibrated with 200  µ l incubation buffer containing 40 m m PIPES, 
100 m m NaCl, 5 m m KCl, 0.1 % glucose, 0.05 % BSA, 2 m m CaCl 2 , 
pH 7.4, and peptidase inhibitors [2 m m bacitracin (Sigma), 0.8 m m 
1,10-phenantroline (Sigma) and 100  µ m captopril (Fluka, Buchs, 
Switzerland) for RB2-overexpressing cells or 0.5 m m bacitracin, 
0.02 m m 1,10-phenantroline and 100  µ m captopril for RB1-bearing 
cells] for 30 min on ice. All further steps were also performed on 
ice. The buffer was removed and the cells were incubated for 90 min 
in 100  µ l of the same buffer solution containing additionally [ 3 H]-
BK (Perkin-Elmer, Waltham, MA, USA) for RB2-binding assay and 
[ 3 H]-DAKD (Perkin-Elmer) for RB1-binding assay, in the concen-
trations of 2 n m and 1 n m , respectively, and tenfold diluted pep-
tide mixtures or fractions after HPLC separations. The calibration 
(displacement) plots were prepared with the solutions of BK, KD, 
MKD (for RB1-and RB2-binding assays), des-Arg 9 -BK, des-Arg 10 -
KD (Bachem) and des-Arg 10 -MKD (obtained by carboxypeptidase 
M-catalyzed degradation of MKD, followed by HPLC purifi ca-
tion) (for RB1-binding assay) at a concentration range of 0.01 – 30 
n m . After incubation, the cells were washed four times with cold 
PBS and treated for 30 min with 200  µ l of dissociative solution, 
0.2 m acetic acid and 0.5 m NaCl pH 2.7, as described previously 
(Faussner et al. , 2005 ). The supernatants containing dissociated 
[ 3 H]-BK or [ 3 H]-DAKD were transferred to scintillation vials fi lled 
with 2.5 ml of scintillation fl uid (Ultima Gold TM , Parkin-Elmer) and 
the radioactivity was measured in a beta-counter (Wallace 1412, 
LKB, Uppsala, Sweden). 
 Detection of IL-1 β and IL-6 secreted by 
U937 cell line 
 U937 cell culture and stimulation: promonocytic U937 cell line 
(ATCC) was grown in HEPES-stabilized RPMI 1640 medium (PAA) 
with  l -glutamine, supplemented with 10 % FBS and streptomycin/
penicillin (0.1 mg/ml), to the maximal density of 10 6 cells/ml, at 
37 ° C in an atmosphere containing 5 % CO 2 . For the cell stimulation, 
4 × 10 6 of undifferentiated cells were incubated with 1 n m BK, KD or 
MKD, various concentrations of peptide mixtures obtained by SAP2 
treatment of LK, SAP2 (as a negative control) and 0.1  µ g/ml LPS 
(Sigma) from  Escherichia coli (as a positive control), at 37 ° C for 
24 h in RPMI medium supplemented with 2 % FBS, protease inhibi-
tor cocktail (Sigma Cat. No P1860) and kininase inhibitors (20  µ m 
captopril, 500  µ m bacitracin and 100  µ m DL-2-mercaptomethyl-3-
guanidinoethylthiopropionic acid (MGTA, Calbiochem-Behring, La 
Jolla, CA) in 250  µ l total volume. 
 ELISA assay: after incubation, the cells were centrifuged and 
IL-1 β and IL-6 concentrations were determined in the supernatants 
by Human IL-1 β ELISA Set II and Human IL-6 ELISA Set (BD 
Biosciences, San Diego, CA, USA), following the manufacturer ’ s 
instruction. Briefl y, ILs from supernatants were bound to microplate-
immobilized antibody and then the secondary biotinylated-antibody 
bound to adsorbed ILs. The amount of bound tracer was determined 
using the SA-HRP/TMB system. The concentrations of ILs were 
estimated from calibration curves prepared with IL standards at a 
concentration range of 3 – 250 pm. 
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